Skip to content
★ Sign in to follow
JC

John C. Jacobs

Executive
Chief Executive Officer
Total declarations
38
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (16 ops.)
€8.1M

Latest filing published 05 Mar 2026 for NOVAVAX INC.

Insider track record

Disclosed buys
0
Disclosed sells
16

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

John C. Jacobs: trading record in brief

John C. Jacobs is a declared insider at 2 companies (chief executive); the most frequent names are Harmony Biosciences Holdings, Inc. and Novavax Inc. We count 38 filings; the first trade dates from 13 September 2021 and the latest from 3 March 2026.

The open-market record consists of 16 sales worth €8.1M, with no purchase. Besides market trades, the filings include 6 share grants and 16 option exercises.

The record was last updated on 5 March 2026 with a share grant (€562k) in Novavax Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to John C. Jacobs

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total

15 of 15 declarations